Asia-Pacific Pharmaceutical (002370) stock introduction, company name: Zhejiang Asia-Pacific Pharmaceutical Co., Ltd., English name: Zhejiang Yatai Pharmaceutical Co., Ltd. A-share code: 002370, A-share stock abbreviation: Asia-Pacific Pharmaceutical Securities Category: Shenzhen Small and Medium Board A-share, Industry: Pharmaceutical Manufacturing Listed Exchange: Shenzhen Stock Exchange. Zhejiang Yatai Pharmaceutical Co., Ltd., formerly known as Zhejiang Yatai Pharmaceutical Factory, was founded in 1989 and located atNo.152, Jiyun Road, Shaoxing County, Zhejiang Province. 200 1 completed the shareholding system reform, and was officially listed on the Shenzhen Stock Exchange on March 10. The company is a professional, large-scale national high-tech enterprise integrating scientific research, production and sales, and a key high-tech enterprise of the National Torch Plan. The company has 1 1 modern pharmaceutical production workshop, including tablets (including penicillins), hard capsules (including cephalosporins and penicillins), transdermal patches (hormones), lyophilized powder for injection, powder for injection (cephalosporins), azithromycin and roxithromycin, and has passed the national GMP quality system certification. Zhejiang Yatai Pharmaceutical Co., Ltd., formerly known as Zhejiang Yatai Pharmaceutical Factory, was founded in 1989 and located atNo.152, Jiyun Road, Shaoxing County, Zhejiang Province. 200 1 completed the shareholding system reform, and was officially listed on the Shenzhen Stock Exchange on March 10. The company is a professional, large-scale national high-tech enterprise integrating scientific research, production and sales, and a key high-tech enterprise of the National Torch Plan. The company has 1 1 modern pharmaceutical production workshop, including tablets (including penicillins), hard capsules (including cephalosporins and penicillins), transdermal patches (hormones), lyophilized powder for injection, powder for injection (cephalosporins), azithromycin and roxithromycin, and has passed the national GMP quality system certification. At present, the company is a "national high-tech enterprise", "national torch plan key high-tech enterprise" and "Zhejiang industrial and commercial enterprise credit A-level contract-abiding and credit-abiding unit". The company's drug research and development centers include "Zhejiang High-tech Research and Development Center", "Zhejiang Enterprise Technology Center" and "Zhejiang Postdoctoral Research Center". Yatai trademark was awarded "Zhejiang Famous Trademark". In the development of new products, we always adhere to the road of scientific and technological innovation. More than 20 technologies have won national patents, and we have domestic first-class quality testing centers, drug research and development centers, unique technologies and scientific management. Relying on China Pharmaceutical University, Shenyang Pharmaceutical University and Institute of Medicine of Zhejiang Academy of Medical Sciences, Zhejiang Asia-Pacific Pharmaceutical Drug R&D Center was established. We have established a professional and efficient new drug research and development team, specializing in transdermal controlled release system, anti-infection, cardiovascular and hypoglycemic fields. In production, the company always strictly controls the quality, and passed the ISO 1400 1 international environmental management system certification in 2002. In operation, the company has always adhered to the promise of "winning with sincerity", and has been rated as an honest enterprise in Shaoxing for four consecutive years, and as a unit of "abiding by contracts and keeping promises" by Zhejiang Industrial and Commercial Bureau. At present, Asia-Pacific Pharmaceutical's products have covered 24 provinces, municipalities and autonomous regions in China, with more than 50 offices in China provinces, and strive to export to many countries and regions.